MENU
+Compare
UTHR
Stock ticker: NASDAQ
AS OF
Oct 10 closing price
Price
$440.00
Change
-$5.38 (-1.21%)
Capitalization
19.9B

UTHR United Therapeutics Corp Forecast, Technical & Fundamental Analysis

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for UTHR with price predictions
Oct 10, 2025

UTHR in +0.83% Uptrend, growing for three consecutive days on October 07, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UTHR advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 17, 2025. You may want to consider a long position or call options on UTHR as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for UTHR moved above the 200-day moving average on September 18, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 261 cases where UTHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for UTHR moved out of overbought territory on October 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where UTHR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for UTHR turned negative on October 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UTHR broke above its upper Bollinger Band on September 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UTHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.774) is normal, around the industry mean (17.691). P/E Ratio (17.167) is within average values for comparable stocks, (72.901). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (1.980). UTHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (6.925) is also within normal values, averaging (47.357).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

UTHR is expected to report earnings to rise 13.73% to $7.29 per share on October 29

United Therapeutics Corp UTHR Stock Earnings Reports
Q3'25
Est.
$7.29
Q2'25
Missed
by $0.94
Q1'25
Beat
by $0.10
Q4'24
Missed
by $0.49
Q3'24
Missed
by $0.14
The last earnings report on July 30 showed earnings per share of $6.41, missing the estimate of $7.35. With 690.86K shares outstanding, the current market capitalization sits at 19.90B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARKA68.32N/A
N/A
ARK 21Shares Active Bitcoin Futures Strategy ETF
EDD5.30-0.04
-0.75%
Morgan Stanley Emerging Markets Domestic Debt Fund
QLTI25.51-0.41
-1.57%
GMO International Quality ETF
FIW111.09-1.77
-1.57%
First Trust Water ETF
AFMC32.83-0.89
-2.65%
First Trust Active Factor Mid Cap ETF

UTHR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with MNKD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-1.21%
MNKD - UTHR
38%
Loosely correlated
-5.06%
GERN - UTHR
37%
Loosely correlated
-6.47%
DAWN - UTHR
37%
Loosely correlated
-2.69%
ALNY - UTHR
36%
Loosely correlated
+0.77%
CBIO - UTHR
36%
Loosely correlated
-7.91%
More

Groups containing UTHR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-1.21%
Pharmaceuticals: Generic
industry (222 stocks)
57%
Loosely correlated
-2.29%
Pharmaceuticals
industry (386 stocks)
26%
Poorly correlated
-2.12%